SGLT2 inhibitors have proven efficacy in slowing chronic kidney disease progression, reducing albuminuria, and decreasing risk of end-stage renal disease
Ideal candidates are those who havent achieved meaningful results with dieting, exercise alone, or non-medical weight-loss programs
A study was conducted in which juvenile rats received oral doses of 4, 10, or 40 mg/kg/day of lisdexamfetamine dimesylate from day 7 to day 63 of age
In mid to late 2025, around 12.4% of US adults reported taking a GLP-1 medicine specifically for weight loss, up from 5.8% in February 2024, according to Gallup survey data of more than 15,000 adults
But focusing on protein, fiber, blood sugar balance, and portion-conscious meals, youre giving your body what it needs to feel good, support your medication, and reach your health goals
This is far more detailed than the basic panels most patients have received from their Primary Care physician before